The Arming of Natural Killer Cells With Fc‐Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells

The Arming of Natural Killer Cells With Fc‐Engineered Monoclonal Antibodies Confers Specificity Against Tumor B Cells

Saved in:

Bibliographic Details
Main Authors:	Michaël Constantinides, Loïs Coënon, Paolo Falvo, Caroline Multrier, Davide Lombardi, Francesco Bertolini, Pierre Martineau, Bruno Robert, Guillaume Cartron, Martin Villalba
Format:	Article
Language:	English
Published:	Wiley 2025-07-01
Series:	MedComm
Subjects:	ADCC B‐cell chronic lymphocytic leukemia engineered mAbs NK cell therapy non‐Hodgkin lymphoma
Online Access:	https://doi.org/10.1002/mco2.70242
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Maximizing activity and selectivity of antibody-mediated effector functions using antibody mixtures
by: Tiexin Wang, et al.
Published: (2025-12-01)

Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
by: Kerry A. Whalen, et al.
Published: (2023-12-01)

Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024-12-01)

Avelumab induces greater Fc-Fc receptor-dependent natural killer cell activation and dendritic cell crosstalk compared to durvalumab
by: Nicole Osborne, et al.
Published: (2025-12-01)

Natural killer cels in immunotherapy for cancer
by: E. A. Borobova, et al.
Published: (2019-01-01)

The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma
by: Léon Raymakers, et al.
Published: (2025-04-01)

Fc-optimized CD276 antibody enhances NK cell activation against non-small cell lung cancer
by: Sylwia A. Stefańczyk, et al.
Published: (2025-07-01)

Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies
by: Chen Gurevitz, et al.
Published: (2024-12-01)

Extranodal Natural Killers/T Cell´s Lymphoma: A case report.
by: Olivia Blanco Pita, et al.
Published: (2023-08-01)

Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody‐dependent cellular cytotoxicity
by: Elaine Branstetter, et al.
Published: (2021-11-01)

Nanomaterial assisted natural killer cell therapy
by: Xuan Yu, et al.
Published: (2025-05-01)

Lower Number and Percentage of Activated Natural Killer Cells in Colorectal Cancer Patients
by: Amie Vidyani, et al.
Published: (2023-01-01)

CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
by: Chiara Giordano, et al.
Published: (2025-01-01)

A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC
by: Huiting Wu, et al.
Published: (2023-12-01)

Enhancing anti-CD3 mAb-mediated diabetes remission in autoimmune diabetes through regulation of dynamin-related protein 1(Drp1)-mediated mitochondrial dynamics in exhausted CD8+T-cell subpopulations
by: Ruiling Zhao, et al.
Published: (2025-03-01)

Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type
by: Satish Maharaj, et al.
Published: (2024-12-01)

Natural Killer Cell and Extracellular Vesicle-Based Immunotherapy in Thyroid Cancer: Advances, Challenges, and Future Perspectives
by: Kruthika Prakash, et al.
Published: (2025-07-01)

Effect of anti-CD4 mAb induced by inhibiting B cell disorder on immune reconstruction of HIV-infected immunological non-responders
by: Yi Ouyang, et al.
Published: (2025-06-01)

mAb production kinetics in CHO batch culture: exploring extracellular and intracellular dynamics
by: Alejandro Avilan Garzon, et al.
Published: (2025-05-01)

Mechanisms of Cbl-Mediated Ubiquitination of Proteins in T and Natural Killer Cells and Effects on Immune Cell Functions
by: Pulak Ranjan Nath, et al.
Published: (2024-12-01)

Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody
by: Hayat Bähr-Mahmud, et al.
Published: (2023-12-01)

Does a natural killer need a CAR?
by: Kangbo Wang, et al.
Published: (2025-06-01)

Unusual Case of Midline Middle Skull Base Lymphoma Mimicking as Invasive Pituitary Adenoma
by: Harish Naik, et al.
Published: (2017-05-01)

Prediction of human pharmacokinetics of Fc-engineered therapeutic monoclonal antibodies using human FcRn transgenic mice
by: Kenta Haraya, et al.
Published: (2025-12-01)

Myeloid/natural killer cell precursor acute leukaemia. Case report and literature review
by: V. R. Gorodetsky, et al.
Published: (2022-11-01)

Natural killer cell memory: challenges and opportunities for cancer immunotherapy
by: Yuhua Qu, et al.
Published: (2024-12-01)

The nonglycosylated variant in therapeutic monoclonal antibodies preferentially forms large aggregates under typical thermal stresses used in forced degradation studies
by: Gao-Yuan Liu, et al.
Published: (2025-12-01)

Flow cytometry analysis of cytotoxic cells in patients with chronic hepatitis C
by: M. S. Selkova
Published: (2014-09-01)

Gene and genotype frequencies of immunoglobulin-like natural killer cell receptors in the population of Samara region
by: D. Yu. Klyuchnikov, et al.
Published: (2023-12-01)

Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy
by: Wenhua Qiao, et al.
Published: (2024-11-01)

Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
by: Wangshu Li, et al.
Published: (2024-12-01)

PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56bright NK CELLS AT PREGNANCY AND IN NON-PREGNANT STATE
by: V. A. Mikhailova, et al.
Published: (2017-01-01)

Super-Charged Natural Killer Cells: A Promising Immunotherapeutic Strategy for Oral Cancer
by: Kawaljit Kaur, et al.
Published: (2025-02-01)

Mechanisms of natural killer cell-mediated clearance of senescent renal tubular epithelial cells
by: Nils David Funk, et al.
Published: (2025-06-01)

Clinicopathological features and treatment of aggressive natural killer cell leukemia: case series and literature review
by: Yongan Ni, et al.
Published: (2024-10-01)

Determination of ultra-trace metal-protein interactions in co-formulated monoclonal antibody drug product by SEC-ICP-MS
by: Laurence Whitty-Léveillé, et al.
Published: (2023-12-01)

Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma
by: Mayuna Nakamura, et al.
Published: (2025-02-01)

Enhancing the physiological characteristics of chimeric antigen receptor natural killer cells by synthetic biology
by: Shuochao Ji, et al.
Published: (2025-04-01)

An intraepithelial ILC1-like natural killer cell subset produces IL-13
by: Sainiteesh Maddineni, et al.
Published: (2025-03-01)

Accelerating Biologics PBPK Modelling with Automated Model Building: A Tutorial
by: Abdallah Derbalah, et al.
Published: (2025-05-01)